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SWITCH: a dynamic CRISPR tool for  
genome engineering and metabolic 
pathway control for cell factory construction 
in Saccharomyces cerevisiae
Katherina García Vanegas1, Beata Joanna Lehka2 and Uffe Hasbro Mortensen1*
Abstract 
Background: The yeast Saccharomyces cerevisiae is increasingly used as a cell factory. However, cell factory construc-
tion time is a major obstacle towards using yeast for bio-production. Hence, tools to speed up cell factory construc-
tion are desirable.
Results: In this study, we have developed a new Cas9/dCas9 based system, SWITCH, which allows Saccharomyces 
cerevisiae strains to iteratively alternate between a genetic engineering state and a pathway control state. Since Cas9 
induced recombination events are crucial for SWITCH efficiency, we first developed a technique TAPE, which we have 
successfully used to address protospacer efficiency. As proof of concept of the use of SWITCH in cell factory construc-
tion, we have exploited the genetic engineering state of a SWITCH strain to insert the five genes necessary for narin-
genin production. Next, the naringenin cell factory was switched to the pathway control state where production was 
optimized by downregulating an essential gene TSC13, hence, reducing formation of a byproduct.
Conclusions: We have successfully integrated two CRISPR tools, one for genetic engineering and one for pathway 
control, into one system and successfully used it for cell factory construction.
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Background
Fermentation offers alternative production of a wide vari-
ety of compounds ranging from primary- and second-
ary metabolites to enzymes and therapeutic proteins. 
Hence, cell factories may replace productions depending 
on polluting resource-demanding petro-chemistry and/
or productions where natural bio-production is difficult, 
unstable, and costly. However, development of new eco-
nomically viable cell factories is often labor intensive, 
technically difficult, and time consuming. New tools to 
speed up and simplify cell factory construction are there-
fore highly desirable as they pave the way for sustainable 
production of high-quality and cost-effective products 
for the benefit of the environment and the consumers [1, 
2].
Although efficient methods for genome engineering 
of popular cell factories like Escherichia coli (E. coli) and 
Saccharomyces cerevisiae (S. cerevisiae) have been availa-
ble for decades, strain development and optimization are 
still time consuming processes requiring a diverse range 
of multidisciplinary techniques, expertise and practical 
skills. One important reason for this is that it is rare that 
one or a few genetic engineering steps lead to formation 
of an efficient cell factory. Rather extensive multi-step 
metabolic engineering and/or tedious improvements via 
classical mutagenesis or evolution based methods are 
required to achieve economically attractive titers. Con-
struction time may therefore be reduced by developing 
general techniques to speed up the experimental cycle 
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for strain construction. Here we address this possibility 
using CRISPR/Cas9 derived technologies for construc-
tion of yeast-based cell factories.
Recently, CRISPR/Cas9 based technologies have been 
introduced as advanced and flexible tools for metabolic 
engineering that may radically speed up cell factory con-
struction. For example, it is well documented that Cas9, 
due to its ability to introduce specific RNA guided DNA 
double strand breaks (DSBs), can be used to greatly stim-
ulate homologous recombination (HR) based genetic 
engineering at specific loci [3, 4]. Accordingly, Cas9 sets 
the stage for modifying several target genes, or introduc-
ing multiple genes, in single transformation experiments 
[5–11]. With Cas9, genetic engineering is so efficient that 
accompanying selection markers are not required. This 
is important, as iterative gene targeting can then be per-
formed without need for marker recycling. Moreover, 
in most cases industrial producer strains do not possess 
e.g. antibiotic resistance marker genes; and engineering 
can therefore be performed in genetic backgrounds that 
are closer to production strains [12]. Another feature of 
CRISPR/Cas9 based technology is its ability to act as a 
target specific synthetic transcriptional regulator. In this 
case, the endonuclease inactive variant dCas9 is targeted 
to relevant promoters via a guide RNA (gRNA) and medi-
ates up- or downregulation of target genes. For example, 
if dCas9 binds to a promoter or in an open reading frame, 
ORF, it may act as a repressor. In this case, the gRNAs 
responsible for the interactions are referred to as interfer-
ence gRNAs. In contrast, by fusing dCas9 to a regulatory 
domain (RD), e.g. VP64, it may act as an activator [13–
15]. Recently, other CRISPR associated nucleases with 
different gRNA binding- and endonucleolytic properties 
have been presented in the literature [16, 17] and these 
nucleases serve as alternatives to Cas9 for genetic engi-
neering. In this paper, we refer to Cas9 and other CRISPR 
associated nucleases as CasX.
Both the genetic engineering and gene regulatory 
aspects of CRISPR/Cas9 have advantageously been 
applied in metabolic engineering strategies for cell fac-
tory construction and optimization. We have there-
fore developed SWITCH that allows a strain to change 
between CasX mediated genetic engineering and dCasX 
mediated regulation states in cycles where switching is 
based on efficient CasX induced recombination events, 
see Fig.  1. One engineering/regulatory cycle is achieved 
by one specific CasX species; a second cycle is achieved 
by another species, and so on. In this way a cell factory 
can either be developed by an optimization cycle where 
the strain alternates between states where it can be 
genetically engineered or states where different levels 
of gene regulation can be implemented. In the present 
paper, we use Cas9 and dCas9 variants to demonstrate 
proof of principle of SWITCH by implementing and tun-
ing the pathway for naringenin (NG), a valuable flavonoid 
possessing strong antioxidant and anti-inflammatory 
activities in vitro and in vivo [18], as a model system.
Results and discussion
SWITCH: a CRISPR based system for rapid genetic 
engineering and pathway tuning
A full cycle of SWITCH requires four steps: (1) specific 
integration of casX, (2) CasX mediated genetic engineer-
ing, (3) replacement of casX for dcasX, (4) specific meta-
bolic tuning mediated by dCasX. In SWITCH casX and 
dcasX gene variants are integrated into well-character-
ized genomic loci exploiting a gene-expression platform 
we have previously developed for S. cerevisiae [19, 20]. 
The platform currently contains 15 integration sites and 
can therefore support 15 SWITCH cycles. In the first 
step of SWITCH, casX is stably integrated into one of the 
specific loci in the yeast expression platform producing 
a strain, which is in the genetic engineering state (Step 
1, Fig. 1). Next, gRNA mediated genetic engineering can 
be iteratively performed. For example, an entire pathway 
may be establish by inserting the individual genes one by 
one using multiple rounds of transformation, or in one 
or a few steps by using e.g. the assembler technology 
(Step 2, Fig.  1) [21]. When genetic engineering is com-
plete, casX can be either eliminated if the strain is ready 
for characterization (Step 3*, Fig. 1), or, substituted for a 
gene encoding a dCasX variant, hence, setting the stage 
for pathway regulation (Step 3, Fig.  1 and Additional 
file  1: Figure S1 for details). In both cases, recombina-
tion is catalyzed by CasX itself and only requires that the 
strain is co-transformed with a plasmid encoding a gRNA 
directing the CasX nuclease to the casX gene and a gene-
targeting substrate containing the dcasX or dcasX-RD 
sequence or a sequence that restores the casX integration 
site. Repair of the resulting DNA DSB in casX using the 
gene-targeting substrate as repair template results in the 
desired replacement of casX with dcasX or dcasX-RD; or 
in restoration of the casX integration site if pathway char-
acterization is the next step. After completing step 3 a 
plasmid-free strain is selected and then transformed with 
a new gRNA encoding plasmid setting the stage for step 
4. In the transformed cells the gRNA directs dCasX-RD 
to gene(s) that are targeted for up- or down-regulation 
(Step 4, Fig. 1). The cycle can be repeated by exploiting 
a new casX/dcasX variant with different gRNA binding 
properties in each cycle.
Testing and optimizing the genetic engineering state 
of SWITCH
We first established Step 1 by integrating a cas9 gene 
(codon optimized for human cells) [22] in strain S-0 (see 
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Table 1). Specifically, cas9 under the control of the TEF1 
promoter was inserted into the X-3 integration site of our 
yeast expression platform [20] using a URA3 marker for 
selection. Transformants were easily obtained and twelve 
clones were randomly picked and tested for the presence 
of cas9 at the X-3 site. All transformants contained cor-
rectly integrated cas9 genes as judged by a PCR based 
test (Additional file 1: Figure S2). For one of these trans-
formants, the URA3 marker was eliminated by direct 
repeat recombination, and the resulting strain S-1, was 
used in further experiments.
Efficient Cas9 mediated marker-free genetic engi-
neering is crucial for SWITCH cell factory construc-
tion. Since specific Cas9 nuclease efficiency depends on 
Step 3
Step 4
Step 1
Step 2 Step 3*
Fig. 1 The SWITCH strategy for cell factory construction and optimization. Step 1 The genomic engineering state is created by integrating casX. 
Note that a direct repeat flanks the KlURA3 marker allowing it to be recycled via direct repeat (DR) recombination. Step 2 In one transformation event 
several genes of interest (GOI) are simultaneously and marker-less integrated by the unified support of assembler and CasX. Step 3 The genomic 
engineering state is switched into the regulatory state, when CasX is directed to cleave its own gene sequence. The rescue DNA fragment contains 
either a codon optimized dcasX or a dcasX fused with a regulatory domain (dcasX ± RD) flanked by regions that are homologous to the integrated 
casX cassette. Alternatively, step 3* if the strain is finalized in step 2, the locus containing casX can be restored to wild type by the assistance of 
CasX and a rescue fragment containing the locus sequence. Step 4 In the regulatory state the regulator protein (dCasX or dCasX-RD) can be used 
to target both endogenous and heterologous GOI. Finally, after both step 3* and 4 the newly created cell factory can be characterized as part of a 
metabolic engineering cycle
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the sequence of the protospacer [23, 24], it is important 
to choose efficient gRNAs. As unrepaired DNA DSBs 
are lethal in S. cerevisiae [25, 26] we envisioned that the 
efficiency of a given gRNA in guiding Cas9 to a specific 
locus will be reflected in cell death in the absence of a 
repair template.
To explore this idea, we individually transformed three 
centromere-based LEU2 plasmids (see “Methods”) encod-
ing three different gRNAs, each of which matches differ-
ent sequences in X3::cas9, as well as a control plasmid 
pRS415 into S-1 strains (Fig.  2a). Despite that we used 
identical concentrations of the four plasmids, the num-
bers of transformants obtained with the plasmids encod-
ing gRNA_14, gRNA_15, and gRNA_16 were reduced 27-, 
3-, and 494-fold, respectively, as compared to the number 
obtained with pRS415; and these differences were all sig-
nificant (p values <0.05). Moreover, the numbers of trans-
formants obtained with gRNA_14 and with gRNA _16 
were significantly different from the number obtained with 
gRNA_15 (p values <0.005). In contrast, the numbers of 
transformants obtained with all four plasmids individually 
transformed into strain S-0, which does not contain the 
cas9 gene, were identical (p value >0.26), see Additional 
file  1: Figure S3. Together these results indicate that the 
three plasmids encoding gRNAs induce cell death in the 
S-1 strain by forming Cas9 mediated DNA DSBs and that 
amongst the three gRNAs, gRNA_14 and gRNA_16 may 
be the best candidates for efficient DNA editing.
Next, we explored whether lethal gRNA-Cas9 induced 
DNA DSBs at cas9 in the X-3 locus could be rescued by 
including a linear X-3 rescue fragment in the transforma-
tion mixture. Indeed, we observed that the numbers of 
transformants obtained with gRNA_14, gRNA_15, and 
gRNA_16 plasmids in S-1 strains could be significantly 
increased by 10-, 1.8-, and 185-fold (p values <0.05), 
respectively, (Fig. 2a). In contrast, when S-1 strains were 
transformed with the control plasmid in the absence or 
presence of the X-3 rescue fragment, the numbers of 
transformants were not significantly different (p value 
0.59) showing that the X-3 rescue fragment alone does 
not increase the transformation efficiency. These results 
strongly indicate that the X-3 rescue fragment can serve 
as a template for HR mediated repair of gRNA-Cas9 
induced DNA DSBs at cas9 during transformation.
Successful repair of gRNA-Cas9 induced DNA DSBs at 
cas9 using the X-3 rescue fragment as template restores 
Table 1 Strains used in this work
Strains Genotype Source
PJ69-4 MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4D gal80D LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ [28]
PJ69-4 S-1 MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4D gal80D LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ X-3::pTEF1-hcas9-tCYC1 This study
PJ69-4 S-2 MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4D gal80D LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ X-3::pTEF1-dcas9-VP64-tCYC1 This study
S-0 MATα Δura3 Δpad1 Δfdc1 Δleu2 Δaro10 This study
S-1 MATα Δura3 Δpad1 Δfdc1 Δleu2 Δaro10 X-3::pTEF1-hcas9_tCYC1 This study
S-2 MATα Δura3 Δpad1 Δfdc1 Δleu2 Δaro10 X-3::pTEF1-hcas9-tCYC1 XI-2::[pTDH3-AtPAL2-tPGI1 TEF2-C4H L5 ATR2-tCYC1 pPGK1-HaCHS-
tENO2 pTEF1-PhCHI-tFBA1 pPDC1-At4Cl2-tTDH2]
This study
S-3 MATα Δura3 Δpad1 Δfdc1 Δleu2 Δaro10 X-3::pTEF1-dcas9-tCYC1 XI-2::[pTDH3-AtPAL2-tPGI1 TEF2-C4H L5 ATR2-tCYC1 pPGK1-HaCHS-
tENO2 pTEF1-PhCHI-tFBA1 pPDC1-At4Cl2-tTDH2]
This study
S-4 MATα Δura3 Δpad1 Δfdc1 Δleu2 Δaro10 XI-2::[pTDH3-AtPAL2-tPGI1 TEF2-C4H L5 ATR2-tCYC1 pPGK1-HaCHS-tENO2 pTEF1-PhCHI-
tFBA1 pPDC1-At4Cl2-tTDH2]
This study
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Fig. 2 Efficient setup for SWITCH. a Screening for gRNAs that effi-
ciently targets Cas9 to the cas9 gene, using TAPE, see text for details. 
b Confirmation of X-3 locus restoration by genomic PCR of 12 clones 
randomly selected amongst the transformants obtained in the pres-
ence of a X-3 rescue fragment. The presence of a 1.5 kb PCR fragment 
indicates that the X-3 locus has been restored
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the X-3 locus at the expense of the cas9 gene. To test 
how efficient the three cas9 specific gRNAs mediate 
this reaction, we analysed twelve randomly selected 
transformants from each of the three co-transformation 
experiments described above by PCR. Our results above 
predict that gRNA_15 is the worst protospacer and that 
gRNA_14 and gRNA_16 are the more efficient proto-
spacers. In agreement with this, only one out of twelve 
transformants obtained with gRNA_15 and the X-3 res-
cue fragment, contained wild-type X-3. In contrast, 
seven and twelve out of twelve transformants obtained 
with gRNA_14 and gRNA_16, respectively, in the pres-
ence of the X-3 rescue fragment contained wild-type X-3 
(Fig.  2b). Hence, with this set of experiments we have 
developed a technique to assess protospacer efficiency, 
which we call TAPE, and used it to make a highly effi-
cient setup for a switch that restores the X-3 locus by 
eliminating cas9 in X-3. Based on these results, we used 
gRNA_16 to replace cas9 with X-3, dcas9 or dcas9-RD in 
all subsequent experiments.
To investigate whether SWITCH, in the genetic engi-
neering state, can be successfully used for construction of 
a cell factory, step 2 in Fig. 1, we used TAPE to identify a 
gRNA that efficiently targets the expression site XI-2. To 
this end, three plasmids encoding different XI-2 specific 
gRNAs were transformed into S-1 (Additional file 1: Fig-
ure S4a). TAPE results indicated that gRNA_23 was the 
most efficient candidate since a plasmid encoding this 
species produced a significantly lower number (>77-fold 
reduced) of transformants as compared to those obtained 
with plasmids encoding gRNA_13, gRNA_22, or no gRNA 
(all p values <0.05), see Additional file 1: Figure S4b.
Using Cas9 induced DNA DSBs to induce marker-
free assembler integration [11], we next attempted to 
integrate all five genes that are required for NG produc-
tion [27] into S-1 (Fig. 3). Accordingly, three assembler 
fragments containing the relevant genes and targeting 
sequences were simultaneously transformed into S-1 
where they were fused and integrated into XI-2 by HR 
(Additional file  1: Figure S5). As expected for low effi-
ciency protospacers, no (p value 0.32) or a low (1.9-fold; 
p value <0.05) increase in number of transformants was 
observed when gRNA_22 and gRNA_13 were trans-
formed into S-1 strains in the presence of assembler 
fragments, as compared to the corresponding numbers 
obtained in their absence. In contrast, with gRNA_23, 
which TAPE identified as a highly efficient protospacer, 
the transformation efficiency was increased more than 
128-fold (p value <0.005) when the assembler frag-
ments were included in the transformation reaction 
as compared to the corresponding numbers obtained 
without the assembler fragments (Additional file 1: Fig-
ure S4b). These results strongly indicate that the assem-
bler fragments were efficiently fused by HR and used 
as a template for repair of the DNA DSBs induced by 
Cas9-gRNA_23. In support of this, 24 randomly picked 
colonies from this experiment all contained the five NG 
genes integrated into XI-2 as judged by PCR analysis 
(Additional file  1: Figure S6a and b). Finally, all strains 
were subjected to metabolite analysis. In agreement with 
the PCR test, the HPLC- UV/DAD analysis showed that 
all 24 strains produced NG (Additional file  1: Figure 
S6c). One random transformant was named strain S-2 
and used to enter step 3.
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Establishment of an efficient cas9–dcas9 gene‑swap 
procedure
A key step, step 3 of SWITCH, is the ability to switch 
the host strain from a Cas9 genetic engineering state to 
a dCas9 regulatory state in a simple and efficient man-
ner. We therefore tested whether Cas9-gRNA_16, which 
efficiently targets cas9 (see above and Additional file  1: 
Figure S1), can be used to catalyze marker-free swap-
ping of cas9 for dcas9 (codon optimized for S. cerevisiae). 
As expected for an efficient protospacer, S-1 derived 
transformants were significantly easier to obtain (p val-
ues <0.05) with the plasmid encoding gRNA_16 in the 
presence of linear marker-free repair fragments (dcas9 
or dcas9-VP64) than in the absence of these fragments. 
In fact, the transformation efficiency with the plasmid 
encoding gRNA_16 was increased 13-fold and 17-fold in 
co-transformation experiments that included the repair 
fragments dcas9 or dcas9-VP64, respectively, as com-
pared to the corresponding transformations that did not 
include repair fragments (Fig. 4a). For both gRNA_16 co-
transformation experiments, twelve transformants were 
analysed by PCR and the results showed that in all cases 
cas9 has been replaced with the sequence contained in 
the repair fragment e.g. either with dcas9 or with dcas9-
VP64 (Fig.  4b). Besides supporting that our system to 
evaluate gRNA proficiency is robust, these results dem-
onstrate that we have developed an efficient cas9–dcas9/
dcas9-RD gene-swap procedure with an efficiency 
approaching 100%.
Synthetic dCas9 derived transcription factors for SWITCH
We then investigated the possibility of using dCas9 and 
dCas9-VP64 as synthetic transcription factors (STFs) in 
our SWITCH setup using gRNAs identified by TAPE. 
For this purpose we employed a two-hybrid strain PJ69-4 
[28] where the native ADE2 gene has been replaced with 
a synthetic reporter gene pGAL2::ADE2, and where the 
gene encoding the Gal4 transcription factor has been 
deleted. We next designed STFs composed by gRNAs 
matching the pGAL2 promoter and dCas9-VP64 and 
tested their ability to activate the synthetic reporter gene 
in two different ways. Firstly, Ade2 activity will allow 
the strains to propagate on medium that does not con-
tain adenine. Secondly, when Ade2 activity is limiting, 
colonies will appear red on medium containing limiting 
amounts of adenine due to accumulation of a metabolic 
intermediate in the purine biosynthesis [29]. In contrast, 
successful activation of pGAL2::ADE2 by dCas9-VP64 
activity will result in white or less red colonies on such a 
medium.
First, we used TAPE to identify gRNAs that effi-
ciently target Cas9 to pGAL2. Accordingly, 15 plasmids, 
each encoding different specific sequences matching 
pGAL2 (Fig.  5a), were tested for their ability to trans-
form a cas9::X-3 strain (PJ69-4 S-1) that also harbors 
the pGAL2::ADE2 assay. With ten of the plasmids more 
than 200 transformants were obtained (Fig. 5b). For the 
remaining five plasmids, significantly less colonies were 
obtained (>8.9 fold reduced; all p values <0.05) indicating 
that the gRNAs encoded by these latter plasmids result in 
severe Cas9 induced cell death.
Next, PJ69-4 S-1 was switched from the genetic engi-
neering state to the regulatory state by co-transformation 
with a plasmid encoding gRNA_16 and a dcas9-VP64 
repair fragment to form strain PJ69-4 S-2. All plasmids 
encoding gRNAs for targeting Cas9 to pGAL2 in PJ69-4 
S-1 were then individually transformed into PJ69-4 S-2.
Transformants obtained with the 15 plasmids were 
randomly picked and tested in a spot assay on solid SC-
Leu-Ade medium (Fig.  5c). PJ69-4 S-2 transformed 
with a control plasmid (pCL1) encoding Gal4 [30] grew 
on this medium and formed a colony patch, but the ten 
transformants harboring a plasmid encoding gRNAs that 
were poor gRNAs, as judged by TAPE, did not propagate. 
In contrast, amongst the five transformants encoding 
efficient gRNAs, two grew on this medium and formed 
colony-patches. The fact that only two of the five effi-
cient gRNAs support growth on this medium may reflect 
that the binding position of STFs on pGAL2 is important 
for inducing transcription of ADE2. To this end we note 
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Fig. 4 By SWITCH, the cas9 gene can be efficiently replaced by dcas9 
and dcas9_VP64 genes. a dcas9 and dcas9_VP64 fragments efficiently 
rescue DNA DSBs formed by Cas9-gRNA_16 in the cas9 gene. b 
Confirmation of SWITCH gene replacements by PCR of 12 randomly 
selected clones co-transformed with gRNA_16 and (top) the dcas9 
rescue fragment and (bottom) the dcas9_VP64 fragment. Diagnos-
tic PCR fragments for dcas9 and dcas9_VP64 are 821 and 977 bp, 
respectively
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that the two proficient STFs bind to the same region of 
pGAL2, (see Fig.  5a). Similar results were observed in 
attempts to activate the CYC1 promoter by STFs [13].
Next, we tested the 15 transformants in a spot-assay on 
solid SC-Leu (Fig. 5c). The ten transformants harboring a 
plasmid encoding gRNAs that were poor gRNAs all pro-
duced red colony-patches. Of the five transformants that 
harbored plasmids encoding efficient gRNAs, the three 
that did not propagate on solid SC-Ade-Leu medium also 
formed red colony patches as expected. However, the 
two transformants that did propagate on solid SC-Ade-
Leu formed colony-patches that were pink in agreement 
with active gene expression from ADE2. We note that the 
control strain expressing GAL4 from the pCL1 plasmid 
formed a white colony-patch indicating that activation of 
ADE2 by Gal4 is stronger than by the two STFs identified 
in this experiment.
Finally using quantitative reverse transcription 
PCR (qRT-PCR), we measured gene expression lev-
els from pGAL2::ADE2 induced by STFs and by Gal4 
and compared the levels to those obtained with ADE2 
in a wild-type strain transformed with the empty plas-
mid pRS415 (Fig.  5d). STF Cas9-gRNA_46 did not sig-
nificantly increase ADE2 expression above background 
levels (p value >0.79); i.e. above levels obtained with a 
pGAL2::ADE2 reference strain transformed with pRS415. 
This finding is in agreement with the fact that STF Cas9-
gRNA_46 did not support growth on solid SC-Ade-Leu 
medium (Additional file  1: Figure S7). Also in agree-
ment with the spot assays, the two STFs, Cas9-gRNA_45 
and Cas9-gRNA_64, which did support growth on solid 
SC-Ade-Leu medium, displayed significantly increased 
ADE2 transcription, 4.0- and 6.2-fold, respectively (both 
p values <0.005). These levels are approximately 41- and 
26-fold lower than the level obtained with Gal4, respec-
tively. The lower ADE2 mRNA levels obtained with the 
two STFs may explain the pink colony phenotype. On 
the other hand, the ADE2 mRNA levels obtained with 
the two STFs Cas9-gRNA_45 and Cas9-gRNA_64 from 
pGAL2::ADE2 are only slightly lower, 2.1- and 1.4-fold, (p 
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values <0.005) than the levels measured from a wild-type 
ADE2 allele.
Using SWITCH in the regulatory state to optimize the 
naringenin pathway
To investigate whether SWITCH can be used to opti-
mize a metabolic pathway we investigated whether the 
NG pathway could be optimized by reducing the activ-
ity of the essential TSC13 gene (see Fig. 3). By reducing 
Tsc13 activity, additional NG is expected as Tsc13 diverts 
coumaroyl-CoA, an intermediate in the NG pathway, 
into a competing pathway. Towards this goal, we first 
used TAPE to identify six efficient TSC13 specific gRNAs 
(gRNA_189–gRNA_194) for targeting Cas9 to the TSC13 
ORF (see Additional file 1: Figure S8a and b).
Next, we switched the cas9 NG strain (S-2) from the 
genetic engineering state to repressive dcas9 regula-
tory state. The resulting dcas9 NG strain (S-3) was then 
transformed with each of the TSC13 interference gRNA 
plasmids and with pRS415 as negative control. For com-
parison, a NG reference strain (S-4) that does not contain 
dCas9 and with restored X-3 locus by SWITCH (Step 3*, 
Fig.  1), was transformed with the same set of plasmids. 
From each transformation plate, six clones were cultured 
in micro-titer dishes using fed-batch medium, where glu-
cose is released by enzymatic hydrolysis of a polysaccha-
ride (see “Methods”).
With all strains, identical final OD600 measurements 
were obtained (p values >0.06) indicating that they all 
contain sufficient Tsc13 activity to sustain wild-type bio-
mass production (Additional file 1: Figure S8c). We then 
determined the effect of the five TSC13 specific gRNAs 
on coumaric acid (COA), NG, and phloretic acid (PHA) 
production by HPLC-UV/DAD analysis.
With all dCas9-gRNA strains significant increases in 
NG production, >30%, were observed as compared to 
NG production in their corresponding reference strains, 
which did not contain dCas9. The biggest increase, 65%, 
was obtained with gRNA_194 (Fig.  6a) and this was 
accompanied by a significant 27% reduction in PHA pro-
duction (Fig.  6b) indicating that the flux towards this 
intermediate was reduced. In addition, strains express-
ing gRNA_194 also accumulated 110% more COA as 
compared to the reference strain (Fig.  6c). This result 
suggests that enzymes downstream of this intermedi-
ate constitute a significant bottleneck in this strain. 
Finally, we also measured TSC13 mRNA levels in this 
set of strains. In all cases we measured significantly 
reduced TSC13 gene activity as compared to the refer-
ence strains (Fig. 6d). Importantly, the largest reduction 
in TSC13 activity (70%) was observed with the strain 
expressing gRNA_194, which is the strain producing the 
highest level of NG. As expected, with the dCas9 strain 
transformed with pRS415, no changes in COA, NG, PHA 
production were observed as compared to the corre-
sponding reference strain; and TSC13 mRNA levels were 
unchanged.
Conclusions and perspectives
CRISPR is increasingly used as a genetic engineering tool 
by exploiting the ability of gRNA-Cas9 to make specific 
DNA DSBs; and as a gene regulatory tool by exploiting 
the ability of gRNA-dCas9 to bind specifically to pro-
moter or ORF sequences. For the first time, we have suc-
cessfully combined these two tools into one system and 
shown that it can be used to establish and optimize a cell 
factory. Specifically, the experiments presented above 
demonstrate that SWITCH can be used to integrate 
and fine tune a metabolic pathway to increase produc-
tion yields. Using a multi-step metabolic engineering 
strategy and a different strain background than ours, 
Koopman et al. 2012 have reported NG titers of 400 µM 
(~108  mg/l). Since down-regulation of TSC13 was not 
included in their strategy, it could be interesting to inves-
tigate whether NG titers could be further increased by 
combining all the genetic features in one strain. In our 
proof of concept setup, the gRNA is transcribed from 
a plasmid as it allowed us to rapidly identify functional 
variants. A further improvement could therefore be to 
integrate the gRNA gene in the genome to avoid using 
selective medium. This would be essential if SWITCH 
mediated pathway fine tuning is applied to a production 
strain. In the present study we have regulated expres-
sion levels of single genes, but more dramatic effects may 
be achieved by up- or down-regulating several genes in 
a metabolic system simultaneously. This principle was 
recently demonstrated by Cheng et  al. 2013 in mam-
malian cells [31]. Moreover, even more complex regula-
tion may be achieved by including new CRISPR related 
nucleases [16, 17] with unique gRNA requirements 
into the SWITCH toolbox. An expanded repertoire of 
CRISPR nucleases can be exploited in SWITCH for itera-
tive cycles of strain engineering and differential tuning 
of individual genes or gene sets. Lastly, we envision that 
SWITCH can be implemented in other species where 
Cas9 stimulated gene targeting is efficient.
Methods
Strains and culture conditions
Escherichia coli DB3.1 competent cells from Invitrogen 
were used as the cloning host for USER vector back-
bones expressing the ccdB gene. Expression vectors were 
cloned using E. coli DH5α competent cells. After trans-
formation, E. coli cells were cultured at 37 °C for at least 
12 h on Luria broth (LB) plates (1% tryptone, 0.5% yeast 
extract, 1% NaCl, 2% Agar) supplemented with 100 mg/l 
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ampicillin. Plasmid rescue cultivations were prepared 
using liquid LB medium with 100 mg/l ampicillin.
Two different S. cerevisiae backgrounds were used: S-0 
derived from S288C (National Collection of Yeast Cul-
tures, UK, NCYC 3608) and the yeast two hybrid (Y2H) 
strain PJ69-4 [28]. Genotypic description of all strains 
can be found in Table  1. Yeast strains were grown on 
liquid YPD medium (1% yeast extract, 2% peptone, 2% 
glucose) for transformation. For vector selection after 
transformation, the strains were cultivated on plates con-
taining synthetic complete (SC) medium minus the cor-
responding auxotrophic marker (1% succinic acid, 0.6% 
NaOH, 0.67% yeast nitrogen base without amino acids, 
1.5% agar) and supplemented with 2% glucose.
For analysis of NG production, small cultivations were 
performed using m2p-labs media development kit for 
glucose-fed batch (M-KIT-100), where glucose is released 
enzymatically through the cultivation according to the 
instructions of the manufacturer. The basic components 
for the fed-batch medium were 2.5% 4× DELFT, 8.55% 
0.5 M citrate, 1.145% 1 M K2HPO4, 0.5% milli-q water, 
50% concentrated polysaccharide, 8% enzyme mixture, 
1% trace metals and 1% vitamins. Small-scale  cultiva-
tions  were carried out in 96 wells microtiter plates at 
400  rpm, 30° and 25  mm amplitude or 280  rpm, 30° 
and 50  mm amplitude. Fed-batch small scale experi-
ments were initiated by inoculating clones into 500  μl 
SC media lacking leucine. After 12  h incubation the 
culture was re-inoculated to reach an OD600 of 0.1 in a 
total volume of 500 μl fed-batch media and incubated for 
72 h. An EnVision 2104 Plate Reader was used for OD600 
measurements.
Primers, plasmids, rescue fragments and USER cloning
All primers were supplied by IDT and are listed in Addi-
tional file 1: Table S1. Plasmids used are listed in Addi-
tional file 1: Table S2.
USER cloning was used to construct integration and 
centromere expression plasmids [32]. PCR USER com-
patible fragments were amplify using PfuX7 polymerase 
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[33]. Backbone plasmids were digested with AsiSI and 
Nb.BsmI (New England Biolabs, 1 U/μl) to remove the 
ccdB gene and create USER compatible ends. Equimo-
lar amounts of purified PCR products and pre-digested 
backbone were mixed to reach a final volume of 8  µl. 
Finally, 1 μl of USER™ enzyme mix (New England Bio-
labs, 1 U/μl) and 1 μl of 10  ×  Standard Taq Reaction 
Buffer (10  mM Tris–HCl, 50  mM KCl, and 1.5  mM 
MgCl2, pH 8.3) were added. The final reaction mixture 
was incubated for 20 min at 37 °C, followed by 20 min at 
25 °C. The treated USER mixture was then used to trans-
form 50 µl of chemically competent  E. coli  cells by heat 
shock.
To generate the different types of cas9 gene fragments 
for integration into the X-3 locus, the human codon opti-
mized cas9 gene from Addgene plasmid #43802 and the 
yeast codon optimized dcas9 from Addgene plasmid 
#64279, were PCR amplified using USER compatible 
primers. The PCR amplified cas9 and dcas9 fragment 
were each cloned into the single integration plasmid X-3 
together with a PCR amplified USER compatible TEF1 
promoter [20]. Fused dcas9 with VP64 was generated by 
ordering a VP64 gblock from IDT which was PCR ampli-
fied using USER compatible primers. The PCR amplified 
TEF1 promoter, dcas9 and VP64 were USER cloned into 
X-3 single integration plasmid.
A compatible uracil excision-based cloning cassette, 
AsiSI/Nb.BsmI-ccdB-AsiSI/Nb.BsmI was USER cloned 
into a USER compatible pRS415 [34] backbone to cre-
ate plasmid pKGV4227. gRNA genes and pSNR52 USER 
compatible fragments were PCR amplified from Addgene 
plasmid #43803 and were clone into pre-digested 
pKGV4227, with AsiSI and Nb.BsmI.
Rescue fragments encoding either dcas9 or dcas9-VP64 
were PCR amplified from plasmids pKGV7 and pKGV5 
respectively, using forward primers (FW) with homol-
ogy to cas9 at the 5′ end and reverse primers (RV) with 
sequence homologous to the nuclear localization signal 
(NLS) and tCYC1 at the 3′ end. A rescue fragment for 
X-3 locus restoration was amplified using genomic DNA 
extracted from s288c.
NG pathway genes were codon optimized for S. cerevi-
siae by GeneArt and assembled into three different con-
structs that were used for HR into the XI-2 locus. Each 
assembler construct was designed to express two genes 
by divergently oriented promoters, which gives the pos-
sibility to integrate up to six genes at one integration site. 
In this study, the first assembler construct expresses the 
Phenylalanine ammonia-lyase 2 (Pal2), under the control 
of pTDH3 and the Cinnamate-4-hydroxylase linked to 
the NADPH-cytochrome P450 reductase 2 (C4H-ATR2), 
under the control of pTEF2. All genes originated from 
Arabidopsis thaliana (At). Assembler-two construct 
contains the Petunia hybrida chalcone-flavonone isomer-
ase A (PhCHI), under the control of pTEF1 and the 
Hypericum androsaemum naringenin-chalcone syn-
thase (HaCHS), under the control of pPGK1. In assem-
bler three 4-coumarate:coenzyme A ligase 2 (At4CL2) 
was express by pPDC1. Assembler one was flanked by 
XI-2 locus DOWN HR and by the divergently oriented 
terminator construct tFBA1-tPGl1. The assembler two 
construct was flanked by two divergently oriented ter-
minators construct tFBA1-tPGl1 and tTDH2-tENO2. 
The assembler three construct was flanked by the diver-
gently oriented terminator construct tTDH2-tENO2 and 
by XI-2 locus UP HR. The assembler fragments were 
integrated via HR by the divergently oriented termina-
tors with each other and with the locus XI-2 by the UP 
and DOWN HR. All PCR results were evaluated using 
Thermo Scientific O’GeneRuler 1 kb DNA Ladder.
Transformation
S. cerevisiae strains were transformed with different com-
binations of either linearized fragments for chromosomal 
integration or with centromere plasmids by the lithium 
acetate transformation method [35]. Prior to transforma-
tion, integrative plasmids were digested with NotI (New 
England Biolabs, 1 U/μl), 400 ng of digested plasmid was 
used for each transformation. For centromere plasmids, 
100 ng DNA was used per transformation. Integration of 
linearized fragments was verified by yeast colony PCR, 
where single colonies were picked from transformation 
plates and pre-treated by boiling in a microwave oven at 
900 watts for 1 min. Amplification was performed using 
Thermo Scientific DreamTaq DNA Polymerase.
Sample preparation and analytical methods
After 72 h of cultivation, OD600 of fed-batch cultures was 
measured using an EnVision 2104 Plate Reader. HPLC 
samples were prepared by extracting the supernatant 
after the culture was diluted 2 times with 96% ethanol. 
HPLC analysis was performed using Thermo Scientific 
Dionex Ultimate3000 equipped with Ultra C18 3 µm Col-
umn (100*4.6  mm). The gradient method mobile phase 
was composed of two solvents, water (A) and acetoni-
trile (B), both buffered with 0.05% trifluoroacetic acid 
(TFA). The column temperature was maintained at 40 °C 
and the flow rate was kept at 1 ml/min. A short program 
was developed for quick screening of NG production, 
where the fraction of solvent B was first increased line-
arly from 15 to 35% (0–3.2 min) and subsequently from 
35 to 100% (3.2–3.5  min). The B fraction remained at 
100% until the end of the program (3.5–4 min). Samples 
used to measure NG and intermediates COA and PHA 
were analyzed using a longer gradient program. Frac-
tion B was increased linearly from 20 to 30% (0–4.5 min) 
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and afterwards from 30 to 60% (4.5–9 min). The B frac-
tion remained at 60% until the end of the program 
(9–9.1  min). In both programs the initial gradient con-
ditions were re-set by an equilibrium program (−3 to 
0 min). The peak area of the compounds was integrated 
and used for quantification by fitting with a standard 
curve.
qRT‑PCR analysis
Yeast RNA was extracted using the RiboPure™-Yeast Kit 
(Thermo Fisher Scientific). Approximately 200 ng of RNA 
was used with the AccuScript High Fidelity 1st Strand 
cDNA Synthesis Kit (Agilent Technologies) and 5  μl of 
cDNA was used for each qPCR reaction, utilizing the 
SYBR® Select Master Mix. qRT-PCR primers are listed 
in Additional file 1: Table S1. qRT-PCR was run and ana-
lysed on the Mx3005P QPCR System (Stratagene), all 
expression levels were normalized to ACT1 mRNA levels.
Statistics
All TAPE values were based on two independent trans-
formations using the same batch of competent yeast cells. 
All relative expression qRT-PCR values were derived 
from single colonies, which were analysed by qRT-PCR in 
technical triplicates. All small scale cultivations for heter-
ologous pathway evaluation were performed as biological 
sextuplicates. In all cases, two-tailed two-sample t tests 
were performed to evaluate whether two average values 
in a specified experimental set were significantly different.
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